Clinicopathological Characteristics of Malignant Eyelid Tumor in Korea.

Park, Ha Na; Jung, Su Kyung; Cho, Won Kyung; Paik, Ji Sun; Yang, Suk Woo

doi:2014.55.3.348

J Korean Ophthalmol Soc > Volume 55(3); 2014 > Article

Original Article

Journal of the Korean Ophthalmological Society 2014;55(3):348-353.
DOI: https://doi.org/10.3341/jkos.2014.55.3.348 Published online March 15, 2014.

Clinicopathological Characteristics of Malignant Eyelid Tumor in Korea.

Ha Na Park, Su Kyung Jung, Won Kyung Cho, Ji Sun Paik, Suk Woo Yang

Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea. yswoph@catholic.ac.kr

한국인 눈꺼풀 악성종양의 임상 양상

박하나⋅정수경⋅조원경⋅백지선⋅양석우

Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea

Abstract

PURPOSE
To determine the clinical characteristics of patients with malignant eyelid tumors in Korea. METHODS: We performed a retrospective review of the medical records of 73 patients with malignant eyelid tumors who were histologically diagnosed at Seoul St. Mary's hospital from April 2004 to September, 2012 and followed for 6 months or longer. RESULTS: Of 73 cases, 41 (56.2%) were diagnosed as basal cell carcinoma, 17 (23.3%) as squamous cell carcinoma, 11 (15.1%) as sebaceous gland carcinoma, 3 (4.1%) as malignant melanoma, and 1 (1.4%) as basosquamous cell carcinoma. The mean age at diagnosis was 68.4 +/- 11.5 years. Tumors developed more commonly on the lower lid (54.8%). Most cases were treated by complete resection of tumors and eyelid reconstruction (95.9%). The prognosis of patients with basal cell carcinoma and squamous cell carcinoma was good, while that of the other tumors was relatively poor. CONCLUSIONS: The most common diagnosis was basal cell carcinoma (56.2%). Recurrence after complete surgical excision and reconstruction was uncommon.

Key Words: Basal cell carcinoma;Malignant eyelid tumor;Sebaceous gland carcinoma;Squamous cell carcinoma